Pulmicort Budesonide

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Pulmicort contains budesonide, an inhaled corticosteroid, supplied as a nebuliser suspension (respules). It is prescribed as a preventer for asthma symptoms and allergic airway conditions, reducing the release of chemical messengers that cause airway swelling. It is not a reliever and will not stop an attack that has already started; benefit builds over several days of regular use.

Active ingredient
Budesonide
Dosage form
Nebuliser suspension (respules)
Therapeutic class
Inhaled corticosteroid
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with budesonide and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Preventer treatment for asthma symptoms
  • Described as used in allergic airway conditions
  • Described as taking several days of regular use before benefit is noticeable
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Used via a nebuliser; check the label and follow the prescriber’s directions on dose and frequency
  • Twist off the top of the respule and squeeze all the liquid into the nebuliser chamber; use immediately after opening
  • The lowest effective dose is advised; rinsing the mouth after use is recommended

Described Side Effects

Commonly described side effects include:

  • Throat irritation or hoarseness
  • Oral thrush (fungal infection of the mouth or throat)
  • Cough
  • Headache

Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • A preventer — not for the relief of a sudden asthma attack
  • Treatment should be continued even when no symptoms are present, unless the prescriber advises otherwise
  • Tuberculosis, a mouth or lung infection, or liver disease should be disclosed to the prescriber
  • Pregnancy or breastfeeding should be discussed with the prescriber

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling, budesonide is an inhaled corticosteroid used as a preventer for asthma symptoms and allergic airway conditions. SDO Pharma has not independently verified these claims.

No. It is described as a preventer and will not stop an asthma attack that has already started.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services